Table 2.
Utilization of lymphedema management modalitiesa
| Modality Prescribed | Baseline (n=139) | 3-months (n=131) | 6-months (n=130) | 12-months (n=125) | Odds Ratio (95% CI)b | P-Value |
|---|---|---|---|---|---|---|
| Exercise | ||||||
| Yes | 81 (58%) | 72 (55%) | 70 (54%) | 68 (54%) | 0.99 (0.96–1.02) | 0.540 |
| No | 58 (42%) | 59 (45%) | 60 (46%) | 57 (46%) | ||
| Pneumatic Compression Pump | ||||||
| Yes | 16 (12%) | 12 (9%) | 14 (11%) | 7 (6%) | 0.94 (0.89–0.98) | 0.005 |
| No | 123 (88%) | 119 (91%) | 116 (89%) | 118 (94%) | ||
| Medications | ||||||
| Yes | 7 (5%) | 7 (5%) | 3 (2%) | 2 (2%) | 0.89 (0.78–1.01) | 0.075 |
| No | 132 (95%) | 124 (95%) | 127 (98%) | 123 (98%) | ||
| Bandaging | ||||||
| Yes | 94 (68%) | 74 (57%) | 78 (60%) | 69 (55%) | 0.96 (0.93–0.99) | 0.011 |
| No | 45 (32%) | 57 (43%) | 52 (40%) | 56 (45%) | ||
| Elevation | ||||||
| Yes | 59 (42%) | 38 (29%) | 49 (38%) | 49 (39%) | 1.00 (0.97–1.04) | 0.666 |
| No | 80 (58%) | 93 (71%) | 81 (62%) | 76 (61%) | ||
| Self-Administered Lymphatic Drainage | ||||||
| Yes | 54 (39%) | 53 (40%) | 49 (38%) | 50 (40%) | 1.01 (0.98–1.05) | 0.402 |
| No | 85 (61%) | 78 (60%) | 81 (62%) | 75 (60%) | ||
| Therapist-Administered Lymphatic Drainage | ||||||
| Yes | 64 (46%) | 40 (31%) | 35 (27%) | 33 (26%) | 0.92 (0.88–0.96) | <0.001 |
| No | 75 (54%) | 91 (69%) | 95 (73%) | 92 (74%) | ||
| Compression Garment | ||||||
| Yes | 110 (79%) | 116 (89%) | 110 (85%) | 105 (84%) | 1.01 (0.96–1.06) | 0.711 |
| No | 29 (21%) | 15 (11%) | 20 (15%) | 20 (16%) | ||
| Skin Care | ||||||
| Yes | 46 (33%) | 49 (37%) | 47 (36%) | 47 (38%) | 1.02 (0.99–1.05) | 0.236 |
| No | 93 (67%) | 82 (63%) | 83 (64%) | 78 (62%) | ||
| Taping | ||||||
| Yes | 11 (8%) | 4 (3%) | 12 (9%) | 11 (9%) | 1.05 (0.97–1.13) | 0.260 |
| No | 128 (92%) | 127 (97%) | 118 (91%) | 114 (91%) | ||
| Anything Else | ||||||
| Yes | 1 (1%) | 1 (1%) | 1 (1%) | 0 (0%) | Insufficient Observationsc | — |
| No | 138 (99%) | 130 (99%) | 129 (99%) | 125 (100%) | ||
|
| ||||||
| Total No. of Lymphedema Management Modalities | β-Coefficientd | |||||
|
| ||||||
| Mean±SD | 3.9±2.2 | 3.6±2.0 | 3.6±2.1 | 3.5±2.1 | −0.02 (−0.05-0.01) | 0.115 |
a
Variables are n (%).
b
Multivariable adjusted longitudinal clustered (to account for repeated observations within subject) logistic regression, adjusting for age, education, race, occupation, time since diagnosis, cancer stage, radiation, chemotherapy, baseline arm volume difference, randomized group assignment, and diagnosis of lymphedema flare in the study. Other variables listed in Table 1 were omitted on the basis of multicollinearity.
c
Due to small cell sizes of these modalities, a statistical model could not be calculated.
d
Multivariable longitudinal regression, adjusting for factors listed above.